“We are pleased to commission the CAB and begin work to deploy the MyCancerJourney platform to improve outcomes for patients with cancer, enhance quality of life and lower costs significantly for patients, self-insured employers and the U.S. healthcare system.”
AUSTIN, Texas (PRWEB) March 18, 2019
POTENTIAMETRICS, an Austin, TX based healthcare data and analytics company, announced the formation of The MyCancerJourney Clinical Advisory Board (CAB) with Jay Piccirillo, M.D. as Chair of the Advisory Board.
“I’m honored to lead this exceptionally talented multi-disciplinary group of specialists, MDs, and medical researchers. As we introduce the CAB over the next several weeks, you’ll recognize their commitment to empowering newly diagnosed cancer by providing information to make more informed decisions related to treatment options”, stated Dr. Piccirillo.
Dr. Piccirillo is a Professor of Otolaryngology at Washington University in St. Louis School of Medicine where he serves as the Vice Chair for Research and Director of the Clinical Outcomes Research Office. Dr. Piccirillo is also Editor in Chief of JAMA – Otolaryngology-Head & Neck Surgery.
MyCancerJourney was developed by Dr. Piccirillo and Researchers at Washington University with the goal to provide patient-specific survival estimates, improve patient decision making and outcomes for newly diagnosed cancer patients.
“We are pleased to commission the CAB and begin work to deploy the MyCancerJourney platform to improve outcomes for patients with cancer, enhance quality of life and lower costs significantly for patients, self-insured employers and the U.S. healthcare system”, noted Kendall Qualls, Chief Commercial Officer for PotentiaMetrics. He continued by saying, “over the next several weeks we’ll introduce the stellar group of physicians, surgeons, researchers that were eager to join our efforts to empower and dramatically change how patients with cancer make decisions about their treatment.
PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.